心血管

订阅

MedSci主页 / 所有栏目 / 心血管

JCEM：食用鸡蛋越多，个体血脂状况更好？

2021-11-08 MedSci原创 MedSci原创

血脂鸡蛋摄入量
关注

在患有慢性代谢紊乱的个体中，较高的鸡蛋摄入量与血脂无关。在没有这种疾病的个体中，食用更多鸡蛋的个体血脂状况更好。该研究的结果支持当前推荐鸡蛋作为健康饮食的指南。

鸡蛋是胆固醇摄入的主要饮食来源之一，但吃鸡蛋越多的人血脂状况是否越差，仍然存在争议。近日，内分泌和代谢性疾病领域权威杂志Journal of Clinical Endocrinology & Metabolism上发表了一篇研究文章，研究人员旨在评估鸡蛋摄入量和血脂参数之间的关系，并探讨了这种关系是否会根据慢性代谢紊乱的存在而改变。

研究人员在EVIDENTII试验中对成年参与者进行了一项多中心横断面研究。调整后的线性回归模型按主要慢性代谢紊乱进行分层。

在728名参与者（61.9%为女性，平均年龄为52.1±11.9岁）中，平均鸡蛋摄入量相当于70公斤个体每周5到6个鸡蛋。在完全调整的分析中，没有发现鸡蛋摄入量与总胆固醇和高密度脂蛋白胆固醇以及甘油三酯水平之间存在关联。此外，与摄入量第一个四分位数相比，第四个四分位数与较低的LDL-c水平（系数为-7.01；95%CI为-13.39，-0.62）和较低的LDL-c/HDL-c比率（系数为-0.24,95%CI为-0.41,-0.06)相关。

在按慢性代谢疾病分层的分析中，较高的鸡蛋摄入量与肥胖、高血压、2型糖尿病、血脂异常或接受降血脂药物治疗的患者血脂状况无关，但与没有这些疾病的参与者更好的血脂状况相关。

由此可见，在患有慢性代谢紊乱的个体中，较高的鸡蛋摄入量与血脂无关。在没有这种疾病的个体中，食用更多鸡蛋的个体血脂状况更好。该研究的结果支持当前推荐鸡蛋作为健康饮食的指南。

原始出处：

Arthur Eumann Mesas.et al.Egg consumption and blood lipid parameters according to the presence of chronic metabolic disorders: The EVIDENT II Study.JCEM.2021.https://academic.oup.com/jcem/advance-article-abstract/doi/10.1210/clinem/dgab802/6420407?redirectedFrom=fulltext

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (16)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1778153, encodeId=9ab31e78153c0, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Wed Nov 17 08:48:15 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063535, encodeId=be0620635355b, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Fri May 06 20:48:15 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069953, encodeId=4ce510699538f, content=认真的学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ced1734358, createdName=1def5843m65(暂无匿称), createdTime=Sat Nov 13 19:12:42 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068909, encodeId=5cfd106890994, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bfd5491875, createdName=ms9000001273668370, createdTime=Wed Nov 10 10:13:02 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068667, encodeId=f586106866eee, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5c0c541ffceb4f11b0948c3e262b6e70/5b6894da824e43cca0ba37dddeca4910.jpg, createdBy=f45a2515633, createdName=药师小王, createdTime=Tue Nov 09 18:21:02 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068661, encodeId=0cda1068661d4, content=👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75f41353134, createdName=751829615, createdTime=Tue Nov 09 18:10:19 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068597, encodeId=4707106859ea7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28955081240, createdName=李美婧, createdTime=Tue Nov 09 14:31:41 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068590, encodeId=5381106859003, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ae45643431, createdName=ms5000000151242792, createdTime=Tue Nov 09 14:13:46 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068586, encodeId=4d11106858660, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12675237246, createdName=147b2883m21暂无昵称, createdTime=Tue Nov 09 13:55:28 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068585, encodeId=6622106858564, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0af75700758, createdName=ms4000001281630229, createdTime=Tue Nov 09 13:48:37 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2021-11-17 仁者大医

    #JCEM#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1778153, encodeId=9ab31e78153c0, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Wed Nov 17 08:48:15 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063535, encodeId=be0620635355b, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Fri May 06 20:48:15 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069953, encodeId=4ce510699538f, content=认真的学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ced1734358, createdName=1def5843m65(暂无匿称), createdTime=Sat Nov 13 19:12:42 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068909, encodeId=5cfd106890994, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bfd5491875, createdName=ms9000001273668370, createdTime=Wed Nov 10 10:13:02 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068667, encodeId=f586106866eee, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5c0c541ffceb4f11b0948c3e262b6e70/5b6894da824e43cca0ba37dddeca4910.jpg, createdBy=f45a2515633, createdName=药师小王, createdTime=Tue Nov 09 18:21:02 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068661, encodeId=0cda1068661d4, content=👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75f41353134, createdName=751829615, createdTime=Tue Nov 09 18:10:19 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068597, encodeId=4707106859ea7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28955081240, createdName=李美婧, createdTime=Tue Nov 09 14:31:41 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068590, encodeId=5381106859003, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ae45643431, createdName=ms5000000151242792, createdTime=Tue Nov 09 14:13:46 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068586, encodeId=4d11106858660, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12675237246, createdName=147b2883m21暂无昵称, createdTime=Tue Nov 09 13:55:28 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068585, encodeId=6622106858564, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0af75700758, createdName=ms4000001281630229, createdTime=Tue Nov 09 13:48:37 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2022-05-06 achengzhao

    #JCE#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1778153, encodeId=9ab31e78153c0, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Wed Nov 17 08:48:15 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063535, encodeId=be0620635355b, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Fri May 06 20:48:15 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069953, encodeId=4ce510699538f, content=认真的学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ced1734358, createdName=1def5843m65(暂无匿称), createdTime=Sat Nov 13 19:12:42 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068909, encodeId=5cfd106890994, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bfd5491875, createdName=ms9000001273668370, createdTime=Wed Nov 10 10:13:02 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068667, encodeId=f586106866eee, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5c0c541ffceb4f11b0948c3e262b6e70/5b6894da824e43cca0ba37dddeca4910.jpg, createdBy=f45a2515633, createdName=药师小王, createdTime=Tue Nov 09 18:21:02 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068661, encodeId=0cda1068661d4, content=👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75f41353134, createdName=751829615, createdTime=Tue Nov 09 18:10:19 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068597, encodeId=4707106859ea7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28955081240, createdName=李美婧, createdTime=Tue Nov 09 14:31:41 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068590, encodeId=5381106859003, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ae45643431, createdName=ms5000000151242792, createdTime=Tue Nov 09 14:13:46 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068586, encodeId=4d11106858660, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12675237246, createdName=147b2883m21暂无昵称, createdTime=Tue Nov 09 13:55:28 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068585, encodeId=6622106858564, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0af75700758, createdName=ms4000001281630229, createdTime=Tue Nov 09 13:48:37 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2021-11-13 1def5843m65(暂无匿称)

    认真的学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1778153, encodeId=9ab31e78153c0, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Wed Nov 17 08:48:15 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063535, encodeId=be0620635355b, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Fri May 06 20:48:15 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069953, encodeId=4ce510699538f, content=认真的学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ced1734358, createdName=1def5843m65(暂无匿称), createdTime=Sat Nov 13 19:12:42 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068909, encodeId=5cfd106890994, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bfd5491875, createdName=ms9000001273668370, createdTime=Wed Nov 10 10:13:02 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068667, encodeId=f586106866eee, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5c0c541ffceb4f11b0948c3e262b6e70/5b6894da824e43cca0ba37dddeca4910.jpg, createdBy=f45a2515633, createdName=药师小王, createdTime=Tue Nov 09 18:21:02 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068661, encodeId=0cda1068661d4, content=👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75f41353134, createdName=751829615, createdTime=Tue Nov 09 18:10:19 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068597, encodeId=4707106859ea7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28955081240, createdName=李美婧, createdTime=Tue Nov 09 14:31:41 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068590, encodeId=5381106859003, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ae45643431, createdName=ms5000000151242792, createdTime=Tue Nov 09 14:13:46 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068586, encodeId=4d11106858660, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12675237246, createdName=147b2883m21暂无昵称, createdTime=Tue Nov 09 13:55:28 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068585, encodeId=6622106858564, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0af75700758, createdName=ms4000001281630229, createdTime=Tue Nov 09 13:48:37 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2021-11-10 ms9000001273668370

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1778153, encodeId=9ab31e78153c0, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Wed Nov 17 08:48:15 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063535, encodeId=be0620635355b, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Fri May 06 20:48:15 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069953, encodeId=4ce510699538f, content=认真的学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ced1734358, createdName=1def5843m65(暂无匿称), createdTime=Sat Nov 13 19:12:42 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068909, encodeId=5cfd106890994, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bfd5491875, createdName=ms9000001273668370, createdTime=Wed Nov 10 10:13:02 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068667, encodeId=f586106866eee, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5c0c541ffceb4f11b0948c3e262b6e70/5b6894da824e43cca0ba37dddeca4910.jpg, createdBy=f45a2515633, createdName=药师小王, createdTime=Tue Nov 09 18:21:02 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068661, encodeId=0cda1068661d4, content=👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75f41353134, createdName=751829615, createdTime=Tue Nov 09 18:10:19 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068597, encodeId=4707106859ea7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28955081240, createdName=李美婧, createdTime=Tue Nov 09 14:31:41 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068590, encodeId=5381106859003, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ae45643431, createdName=ms5000000151242792, createdTime=Tue Nov 09 14:13:46 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068586, encodeId=4d11106858660, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12675237246, createdName=147b2883m21暂无昵称, createdTime=Tue Nov 09 13:55:28 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068585, encodeId=6622106858564, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0af75700758, createdName=ms4000001281630229, createdTime=Tue Nov 09 13:48:37 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2021-11-09 药师小王

    学习了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1778153, encodeId=9ab31e78153c0, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Wed Nov 17 08:48:15 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063535, encodeId=be0620635355b, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Fri May 06 20:48:15 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069953, encodeId=4ce510699538f, content=认真的学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ced1734358, createdName=1def5843m65(暂无匿称), createdTime=Sat Nov 13 19:12:42 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068909, encodeId=5cfd106890994, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bfd5491875, createdName=ms9000001273668370, createdTime=Wed Nov 10 10:13:02 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068667, encodeId=f586106866eee, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5c0c541ffceb4f11b0948c3e262b6e70/5b6894da824e43cca0ba37dddeca4910.jpg, createdBy=f45a2515633, createdName=药师小王, createdTime=Tue Nov 09 18:21:02 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068661, encodeId=0cda1068661d4, content=👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75f41353134, createdName=751829615, createdTime=Tue Nov 09 18:10:19 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068597, encodeId=4707106859ea7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28955081240, createdName=李美婧, createdTime=Tue Nov 09 14:31:41 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068590, encodeId=5381106859003, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ae45643431, createdName=ms5000000151242792, createdTime=Tue Nov 09 14:13:46 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068586, encodeId=4d11106858660, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12675237246, createdName=147b2883m21暂无昵称, createdTime=Tue Nov 09 13:55:28 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068585, encodeId=6622106858564, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0af75700758, createdName=ms4000001281630229, createdTime=Tue Nov 09 13:48:37 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2021-11-09 751829615

    👍

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1778153, encodeId=9ab31e78153c0, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Wed Nov 17 08:48:15 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063535, encodeId=be0620635355b, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Fri May 06 20:48:15 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069953, encodeId=4ce510699538f, content=认真的学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ced1734358, createdName=1def5843m65(暂无匿称), createdTime=Sat Nov 13 19:12:42 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068909, encodeId=5cfd106890994, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bfd5491875, createdName=ms9000001273668370, createdTime=Wed Nov 10 10:13:02 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068667, encodeId=f586106866eee, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5c0c541ffceb4f11b0948c3e262b6e70/5b6894da824e43cca0ba37dddeca4910.jpg, createdBy=f45a2515633, createdName=药师小王, createdTime=Tue Nov 09 18:21:02 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068661, encodeId=0cda1068661d4, content=👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75f41353134, createdName=751829615, createdTime=Tue Nov 09 18:10:19 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068597, encodeId=4707106859ea7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28955081240, createdName=李美婧, createdTime=Tue Nov 09 14:31:41 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068590, encodeId=5381106859003, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ae45643431, createdName=ms5000000151242792, createdTime=Tue Nov 09 14:13:46 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068586, encodeId=4d11106858660, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12675237246, createdName=147b2883m21暂无昵称, createdTime=Tue Nov 09 13:55:28 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068585, encodeId=6622106858564, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0af75700758, createdName=ms4000001281630229, createdTime=Tue Nov 09 13:48:37 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2021-11-09 李美婧

    学习

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1778153, encodeId=9ab31e78153c0, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Wed Nov 17 08:48:15 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063535, encodeId=be0620635355b, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Fri May 06 20:48:15 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069953, encodeId=4ce510699538f, content=认真的学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ced1734358, createdName=1def5843m65(暂无匿称), createdTime=Sat Nov 13 19:12:42 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068909, encodeId=5cfd106890994, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bfd5491875, createdName=ms9000001273668370, createdTime=Wed Nov 10 10:13:02 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068667, encodeId=f586106866eee, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5c0c541ffceb4f11b0948c3e262b6e70/5b6894da824e43cca0ba37dddeca4910.jpg, createdBy=f45a2515633, createdName=药师小王, createdTime=Tue Nov 09 18:21:02 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068661, encodeId=0cda1068661d4, content=👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75f41353134, createdName=751829615, createdTime=Tue Nov 09 18:10:19 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068597, encodeId=4707106859ea7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28955081240, createdName=李美婧, createdTime=Tue Nov 09 14:31:41 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068590, encodeId=5381106859003, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ae45643431, createdName=ms5000000151242792, createdTime=Tue Nov 09 14:13:46 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068586, encodeId=4d11106858660, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12675237246, createdName=147b2883m21暂无昵称, createdTime=Tue Nov 09 13:55:28 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068585, encodeId=6622106858564, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0af75700758, createdName=ms4000001281630229, createdTime=Tue Nov 09 13:48:37 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2021-11-09 ms5000000151242792

    有意思

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1778153, encodeId=9ab31e78153c0, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Wed Nov 17 08:48:15 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063535, encodeId=be0620635355b, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Fri May 06 20:48:15 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069953, encodeId=4ce510699538f, content=认真的学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ced1734358, createdName=1def5843m65(暂无匿称), createdTime=Sat Nov 13 19:12:42 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068909, encodeId=5cfd106890994, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bfd5491875, createdName=ms9000001273668370, createdTime=Wed Nov 10 10:13:02 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068667, encodeId=f586106866eee, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5c0c541ffceb4f11b0948c3e262b6e70/5b6894da824e43cca0ba37dddeca4910.jpg, createdBy=f45a2515633, createdName=药师小王, createdTime=Tue Nov 09 18:21:02 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068661, encodeId=0cda1068661d4, content=👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75f41353134, createdName=751829615, createdTime=Tue Nov 09 18:10:19 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068597, encodeId=4707106859ea7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28955081240, createdName=李美婧, createdTime=Tue Nov 09 14:31:41 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068590, encodeId=5381106859003, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ae45643431, createdName=ms5000000151242792, createdTime=Tue Nov 09 14:13:46 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068586, encodeId=4d11106858660, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12675237246, createdName=147b2883m21暂无昵称, createdTime=Tue Nov 09 13:55:28 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068585, encodeId=6622106858564, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0af75700758, createdName=ms4000001281630229, createdTime=Tue Nov 09 13:48:37 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2021-11-09 147b2883m21暂无昵称

    学习了

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1778153, encodeId=9ab31e78153c0, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Wed Nov 17 08:48:15 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2063535, encodeId=be0620635355b, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Fri May 06 20:48:15 CST 2022, time=2022-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069953, encodeId=4ce510699538f, content=认真的学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ced1734358, createdName=1def5843m65(暂无匿称), createdTime=Sat Nov 13 19:12:42 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068909, encodeId=5cfd106890994, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6bfd5491875, createdName=ms9000001273668370, createdTime=Wed Nov 10 10:13:02 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068667, encodeId=f586106866eee, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201120/5c0c541ffceb4f11b0948c3e262b6e70/5b6894da824e43cca0ba37dddeca4910.jpg, createdBy=f45a2515633, createdName=药师小王, createdTime=Tue Nov 09 18:21:02 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068661, encodeId=0cda1068661d4, content=👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75f41353134, createdName=751829615, createdTime=Tue Nov 09 18:10:19 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068597, encodeId=4707106859ea7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28955081240, createdName=李美婧, createdTime=Tue Nov 09 14:31:41 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068590, encodeId=5381106859003, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7ae45643431, createdName=ms5000000151242792, createdTime=Tue Nov 09 14:13:46 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068586, encodeId=4d11106858660, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12675237246, createdName=147b2883m21暂无昵称, createdTime=Tue Nov 09 13:55:28 CST 2021, time=2021-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1068585, encodeId=6622106858564, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0af75700758, createdName=ms4000001281630229, createdTime=Tue Nov 09 13:48:37 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2021-11-09 ms4000001281630229

    好的

    0

以上为热门评论，梅斯医学App还有更多内容

相关资讯

常规检验重大缺陷！普通血脂正常未必正常！

近年来，普通血脂体检越来越普及，大部分公众每年都做普通血脂体检，但心脑血管慢性病发生率并没有明显下降，令人深思！有果必有因，公众每年普通血脂体检，挡不住慢病高发生率步伐，是因为没有找到导致心脑血管疾病

Nature子刊：癌症幸存者血脂四项出现这些变化，小心心梗和卒中！

Scientifc Reports：既往癌症和随后心肌梗死或中风患者的脂质谱和预后

《科学》子刊：低血红蛋白可以预防肥胖？

血红蛋白水平与身体质量指数、葡萄糖代谢、血脂和血压有关，血红蛋白水平较低的参与者在代谢方面更好。

JAHA：沙比特利/缬沙坦对射血分数正常的心衰患者血脂的影响

与缬沙坦相比，沙比特利/缬沙坦治疗可显著降低甘油三酯水平，并且这种效应在基线时甘油三酯升高的患者中明显更强。研究人员还观察到HDL-c和LDL-c胆固醇适度增加。HDL-c和甘油三酸酯变化的潜在机制。

降血脂有妙招？医生开出了4张处方！

饮食+运动！

ATVB：血脂与COVID-19风险之间的因果关系

该研究的结果表明较高的总胆固醇和ApoB水平可能会增加感染COVID-19的风险。